Monthly Archives: October 2016

Everolimus provides some benefit for people with papillary renal cell cancer

By Sharon Kell|2016-10-06T14:43:26+00:006 Oct 2016|Drug treatments|

A study published in the European Journal of Cancer shows that [...]

Comments Off

A combination of immunotherapies may hold promise for kidney cancer

By Sharon Kell|2016-10-06T13:28:56+00:006 Oct 2016|Drug treatments|

A combination of the PD-1 inhibitor pembrolizumab (Keytruda) with another [...]

Comments Off

New NHS England cancer ratings published

By Sharon Kell|2016-10-05T16:10:28+00:005 Oct 2016|Cancer news|

NHS England has today published new ratings providing a snapshot [...]

Comments Off

Eisai has started phase III clinical trial with lenvatinib as a potential first-line treatment for advanced kidney cancer

By Sharon Kell|2016-10-05T11:08:53+00:005 Oct 2016|Drug treatments|

This week saw the initiation of a global phase III [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Our Website Design Specialist | Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org